Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

NCT05861869 is registered in ClinicalTrials.gov with Zhejiang Biostar Biotechnology Co. as lead sponsor.

NCT NCT05861869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05861869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)
Lead sponsor
Zhejiang Biostar Biotechnology Co.
Phase
Observational
Overall status
Unknown status
Start date
May 4, 2023
Completion date
June 30, 2024
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases-except membranous nephropathy, membranous nephropathy - pla2r induced